Aurora Cannabis (ACB) Income from Non-Controlling Interests (2018 - 2026)

Aurora Cannabis (ACB) posted quarterly Income from Non-Controlling Interests of $7.3 million for Q1 2026, up 435.49% year-on-year from $1.4 million in Q1 2025, and up 371.88% on a QoQ basis from -$2.7 million in Q4 2025.

Aurora Cannabis (ACB) Income from Non-Controlling Interests (2018 - 2026) Analysis & Trends

Aurora Cannabis (ACB) has reported Income from Non-Controlling Interests for 8 consecutive years, with $7.3 million the latest figure, recorded in Q1 2026.

  • Quarterly Income from Non-Controlling Interests rose 435.49% year-over-year to $7.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $84057.7 (up 115.06% YoY) and the FY2025 annual result came in at -$487005.4, up 82.47% from the prior year.
  • Income from Non-Controlling Interests grew to $7.3 million in Q1 2026 per ACB's latest filing, from -$2.7 million in the prior quarter.
  • Over the last five years, Income from Non-Controlling Interests for ACB reached as high as $7.3 million in Q1 2026 and fell as low as -$3.4 million in Q2 2025.
  • A 5-year average of -$260930.5 and a median of -$677341.4 in 2024 frame the typical range for Income from Non-Controlling Interests.
  • Annual changes were most pronounced in 2025 — Income from Non-Controlling Interests slumped 1044.0% — and 2026, when it soared 435.49%.
  • Year by year, Income from Non-Controlling Interests stood at -$1.5 million in 2022, then jumped by 48.58% to -$781545.8 in 2023, then surged by 70.14% to -$233366.8 in 2024, then sank by 1044.0% to -$2.7 million in 2025, then surged by 371.88% to $7.3 million in 2026.
  • According to Business Quant data, Income from Non-Controlling Interests over the past three periods registered $7.3 million, -$2.7 million, and -$1.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Haleon 89.86 Bn 88.00 Bn - -
2 Teva Pharmaceutical Industries 35.89 Bn 32.15 Bn 1.97 Bn -
3 Zoetis 32.57 Bn 30.63 Bn 1.62 Bn -
4 Takeda Pharmaceutical 27.54 Bn 23.48 Bn 4.39 Bn 395,346.10
5 United Therapeutics 23.06 Bn 20.90 Bn 648.10 Mn -
6 RedHill Biopharma 21.48 Bn 21.48 Bn - -
7 Viatris 20.43 Bn 18.62 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.81 Bn 16.49 Bn 800.70 Mn -12.70 Mn
9 Elanco Animal Health 12.61 Bn 12.18 Bn 785.00 Mn -
10 Aurora Cannabis 155.11 Mn 69.87 Mn 21.72 Mn 7.26 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 7.26 Mn
Dec 31, 2025 -2.67 Mn
Sep 30, 2025 -1.14 Mn
Jun 30, 2025 -3.36 Mn
Mar 31, 2025 1.36 Mn
Dec 31, 2024 -233,366.82
Sep 30, 2024 -677,341.35
Jun 30, 2024 -1.00 Mn
Mar 31, 2024 264,934.42
Dec 31, 2023 -781,545.80
Sep 30, 2023 -1.20 Mn
Dec 31, 2022 -1.52 Mn
Sep 30, 2022 -216,989.19
Jun 30, 2022 8,627.75
Mar 31, 2022 1,578.95
Dec 31, 2021 -291,154.34
Sep 30, 2020 -1.10 Mn
Sep 30, 2018 -979,927.44